Accuracy of Xpert® MTB/RIF Ultra test for posterior oropharyngeal saliva for the diagnosis of paucibacillary pulmonary tuberculosis: a prospective multicenter study

References

• WHO. Global tuberculosis report 2021. Geneva: World Health Organization; 2021.
   Google Scholar
• Floyd K, Glaziou P, Zumla A, et al. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. Lancet Respir Med. 2018;6(4):299–314.
   PubMed Web of Science ®Google Scholar
• Lin HH, Dowdy D, Dye C, et al. The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ. 2012;90(10):739–747A.
   PubMed Web of Science ®Google Scholar
• Theron G, Peter J, Meldau R, et al. Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid. Thorax. 2013;68(11):1043–1051.
   PubMed Web of Science ®Google Scholar
• Steingart KR, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(10):664–674.
   PubMed Web of Science ®Google Scholar
• MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 2020;58(10):e01582-19.
   PubMed Web of Science ®Google Scholar
• WHO. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization; 2013.
   Google Scholar
• Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064.
   PubMed Web of Science ®Google Scholar
• Tang P, Liang E, Zhang X, et al. Prevalence and risk factors of subclinical tuberculosis in a low-incidence setting in China. Front Microbiol. 2021;12:731532.
   PubMed Web of Science ®Google Scholar
• McWilliams T, Wells AU, Harrison AC, et al. Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax. 2002;57(12):1010–1014.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
   PubMed Web of Science ®Google Scholar
• Wong SCY, Tse H, Siu HK, et al. Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(11):2939–2946.
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio. 2017;8(4):e00812-17.
   PubMed Web of Science ®Google Scholar
• Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84.
   PubMed Web of Science ®Google Scholar
• Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768.
   PubMedGoogle Scholar
• Sossen B, Broger T, Kerkhoff AD, et al. “SILVAMP TB LAM” rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South Africa. Clin Infect Dis. 2020;71(8):1973–1976.
   PubMed Web of Science ®Google Scholar
• Jacobson KR, Sabin LL. Scaling up multidrug-resistant tuberculosis care in China. Lancet Glob Health. 2015;3(4):e183–e184.
   PubMed Web of Science ®Google Scholar
• Achkar JM, Lawn SD, Moosa MY, et al. Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis. 2011;204(Suppl 4):S1130–S1141.
   PubMedGoogle Scholar
• Brown M, Varia H, Bassett P, et al. Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. Clin Infect Dis. 2007;44(11):1415–1420.
   PubMed Web of Science ®Google Scholar
• Hepple P, Ford N, McNerney R. Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review. Int J Tuberc Lung Dis. 2012;16(5):579–588.
   PubMed Web of Science ®Google Scholar
• Shenai S, Amisano D, Ronacher K, et al. Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay. J Clin Microbiol. 2013;51(12):4161–4166.
   PubMed Web of Science ®Google Scholar
• Byanyima P, Kaswabuli S, Musisi E, et al. Feasibility and sensitivity of saliva GeneXpert MTB/RIF Ultra for tuberculosis diagnosis in adults in Uganda. Microbiol Spectr. 2022;10(5):e0086022.
   PubMedGoogle Scholar
• Mishra H, Reeve BWP, Palmer Z, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study. Lancet Respir Med. 2020;8(4):368–382.
   PubMed Web of Science ®Google Scholar
• Kendall EA, Shrestha S, Dowdy DW. The epidemiological importance of subclinical tuberculosis. A critical reappraisal. Am J Respir Crit Care Med. 2021;203(2):168–174.
   PubMed Web of Science ®Google Scholar
• Frascella B, Richards AS, Sossen B, et al. Subclinical tuberculosis disease-a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology. Clin Infect Dis. 2021;73(3):e830–ee41.
   PubMed Web of Science ®Google Scholar
• Donovan J, Thu DDA, Phu NH, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis. 2020;20(3):299–307.
   PubMed Web of Science ®Google Scholar
• Opota O, Zakham F, Mazza-Stalder J, et al. Added value of Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in a low-prevalence setting. J Clin Microbiol. 2019;57(2):e01717-18.
   PubMed Web of Science ®Google Scholar
• Huo F, Ma Y, Liu R, et al. Interpretation of discordant rifampicin susceptibility test results obtained using GeneXpert vs phenotypic drug susceptibility testing. Open Forum Infect Dis. 2020;7(8):ofaa279.
   PubMed Web of Science ®Google Scholar
• Ocheretina O, Byrt E, Mabou MM, et al. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis. 2016;85(1):53–55.
   PubMed Web of Science ®Google Scholar
• Roychowdhury T, Mandal S, Bhattacharya A. Analysis of IS6110 insertion sites provide a glimpse into genome evolution of mycobacterium tuberculosis. Sci Rep. 2015;5:12567.
   PubMed Web of Science ®Google Scholar
• Pang Y, Zhou Y, Zhao B, et al. Spoligotyping and drug resistance analysis of mycobacterium tuberculosis strains from national survey in China. PLoS One. 2012;7(3):e32976.
   PubMed Web of Science ®Google Scholar